Calamos Advisors
MYOK

Calamos Advisors’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Calamos Advisors’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-63,551
Closed -$8.66M – 779
2020
Q3 		$8.66M Buy
63,551
+22,706
+56% +$2.41M 0.06% 337
2020
Q2 		$3.94M Buy
40,845
+18,308
+81% +$1.53M 0.03% 494
2020
Q1 		$1.06M Buy
+22,537
New +$1.44M 0.01% 594

Calamos Advisors's MYOK Position: Q4 2020 in Review

Calamos Advisors sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 63,551 shares — an estimated $8.66M sold.

Calamos Advisors first reported a position in MYOK in Q1 2020 and held it in 3 quarters. The position peaked at $8.66M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • Calamos Advisors reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Calamos Advisors sold 63,551 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $8.66M.
  • Calamos Advisors first reported a position in MyoKardia, Inc. Common Stock in Q1 2020 and held it in 3 quarters.
  • Calamos Advisors's MyoKardia, Inc. Common Stock position peaked at $8.66M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Calamos Advisors's 13F filing for Q4 2020, filed 27 Jan 2021.